These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32362830)

  • 1. Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1α/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells.
    Liu X; Zhou Y; Peng J; Xie B; Shou Q; Wang J
    Front Pharmacol; 2020; 11():495. PubMed ID: 32362830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer.
    Zhang YF; Zhang ZH; Li MY; Wang JY; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Zuo HX; Jin HL; Ma J; Jin X
    Phytomedicine; 2021 Jan; 81():153425. PubMed ID: 33310309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells.
    Li M; Yu X; Guo H; Sun L; Wang A; Liu Q; Wang X; Li J
    Tumour Biol; 2014 Mar; 35(3):2461-71. PubMed ID: 24218335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma.
    Yang Q; Wu H; Wang H; Li Y; Zhang L; Zhu L; Wang W; Zhou J; Fu Y; Chen S; Wu Q; Chen C; Zhou C
    Int J Oncol; 2017 Apr; 50(4):1160-1174. PubMed ID: 28350074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α/SDF-1/CXCR4 axis reduces neuronal apoptosis via enhancing the bone marrow-derived mesenchymal stromal cell migration in rats with traumatic brain injury.
    Guo K; Yao X; Wu W; Yu Z; Li Z; Ma Z; Liu D
    Exp Mol Pathol; 2020 Jun; 114():104416. PubMed ID: 32165091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-α pathway.
    Su S; Dou H; Wang Z; Zhang Q
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):224-233. PubMed ID: 32905663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway.
    Ju Q; Shi Q; Liu C; Fu G; Shi H
    J Thorac Dis; 2023 Apr; 15(4):2141-2160. PubMed ID: 37197494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
    Weekes CD; Song D; Arcaroli J; Wilson LA; Rubio-Viqueira B; Cusatis G; Garrett-Mayer E; Messersmith WA; Winn RA; Hidalgo M
    Neoplasia; 2012 Aug; 14(8):690-701. PubMed ID: 22952422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α.
    Zhao Z; Liu L; Chen H; Li S; Guo Y; Hou X; Yang J
    Front Pharmacol; 2023; 14():1138265. PubMed ID: 37324458
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1α.
    Huang X; Zhou J; Liu J; Tang B; Zhao F; Qu Y
    Oncol Lett; 2014 Sep; 8(3):1217-1221. PubMed ID: 25120692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of hypoxia-inducible factor 1alpha on the biological characteristics of the SiHa uterine cervix cancer cell line.
    Tang B; Qu Y; Zhao F; Mao M; Tang J; Li X; Ferriero D; Mu D
    Int J Gynecol Cancer; 2009 Jul; 19(5):898-904. PubMed ID: 19574782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.
    Pan F; Ma S; Cao W; Liu H; Chen F; Chen X; Shi R
    Mol Biol Rep; 2013 Jul; 40(7):4139-46. PubMed ID: 23712777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc/HIF-1α pathway.
    Liu J; Huang X; Liu D; Ji K; Tao C; Zhang R; Chen J
    Phytomedicine; 2021 Oct; 91():153678. PubMed ID: 34385092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariin promotes the migration of bone marrow stromal cells via the SDF-1α/HIF-1α/CXCR4 pathway.
    Zhu H; Wang X; Han Y; Zhang W; Xin W; Zheng X; Zhang J
    Drug Des Devel Ther; 2018; 12():4023-4031. PubMed ID: 30538428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
    Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
    Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis.
    Jin J; Yao Z; Qin H; Wang K; Xin X
    Biotechnol Lett; 2021 Jun; 43(6):1229-1240. PubMed ID: 33534015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway.
    Guo W; Ding Y; Pu C; Wang Z; Deng W; Jin X
    J Gastrointest Oncol; 2022 Dec; 13(6):3254-3262. PubMed ID: 36636058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.